Page last updated: 2024-12-08
hexacyanochromate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
hexacyanochromate: paramagnetic anion probe for active sites of enzymes; RN refers to tri-K salt; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 159689 |
MeSH ID | M0075478 |
Synonyms (11)
Synonym |
---|
hexacyanochromate |
tripotassium hexacyanochromate |
tripotassium hexa(cyano-c)chromate(3-) |
einecs 237-079-8 |
(oc-6-11)-tripotassium hexakis(cyano-c)chromate(3-) |
hexakis(cyano-c)chromate(3-) tripotassium |
chromate(3-), hexakis(cyano-kappac)-, tripotassium, (oc-6-11)- |
chromate(3-), hexakis(cyano-kappac)-, potassium (1:3), (oc-6-11)- |
chromate(3-), hexakis(cyano-.kappa.c)-, tripotassium, (oc-6-11)- |
DTXSID10929218 |
tripotassium;chromium(3+);hexacyanide |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 33.48
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (33.48) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |